CoreRx Expands Manufacturing and Marketing Staff to Mirror Growth into their State-of-the Art cGMP Facility
Published: Jul 30, 2012
"Our customer-first attention to detail is sparking continued growth," explained CoreRx’s VP of Business Operations Jim Davis, "and because of this we need to expand our sales and marketing coverage as well as our expansion into commercial manufacturing."
Joining CoreRx, with 21 years of experience, is Director of Commercial Manufacturing, Simon Daw. Simon was formerly Manufacturing Manager at DSM Pharmaceuticals in Greenville, NC where he was responsible for overseeing a manufacturing group of over 50 in four shifts. At DSM his group was responsible for compression, encapsulation, coating and technical services. Prior to working at DSM he was plant manager at Lannett Company in Philadelphia, PA. Simon has extensive experience in the pharmaceutical industry in solid dosage form manufacturing.
Also joining CoreRx as Manager of Marketing and Strategic Development is Jenna Leitao. Jenna comes to CoreRx with proven experience in creative marketing as an Account Executive at Fourthdoor Creative Group. Jenna’s primary role at CoreRx is to focus on brand management, advertising and overall strategic marketing. As a member of the marketing team, Jenna’s corporate, customer and industry perspective will be a valuable asset as CoreRx continues to grow in becoming the premier provider of product development services in the pharmaceutical and biotech community.
CoreRx is a contract research organization providing customized pre-formulation services, formulation development, manufacturing and analytical services to pharmaceutical, biotechnology, academic and veterinary clients. The company is renowned for reliably expediting early development activities to speed potential drugs to clinical trials while applying stage-specific scientific knowledge and experience. CoreRx's unique corporate structure creates project teams that work intensively with each client, bringing an extension of their own organization into the CoreRx lab.
As a fully cGMP contract facility, CoreRx provides formulation development, analytical, and clinical material resources, utilizing a variety of multi-layer tablet equipment for combination products. CoreRx also offers development and manufacture of multi-particulate combination drug products. Whether your need is for multiple tablets in a capsule, pellets, granules, nano-particles, co-processed spray dried powders or multiple powders in capsules, CoreRx has you covered.
Keep on top of new developments and throughout the drug development industry by following us on Twitter www.twitter.com/CoreRx. For more detailed information about us, visit www.corerxpharma.com.